Lewy pathology in Parkinson's disease consists of crowded organelles and lipid membranes.


Journal

Nature neuroscience
ISSN: 1546-1726
Titre abrégé: Nat Neurosci
Pays: United States
ID NLM: 9809671

Informations de publication

Date de publication:
07 2019
Historique:
received: 26 10 2018
accepted: 09 05 2019
entrez: 26 6 2019
pubmed: 27 6 2019
medline: 19 7 2019
Statut: ppublish

Résumé

Parkinson's disease, the most common age-related movement disorder, is a progressive neurodegenerative disease with unclear etiology. Key neuropathological hallmarks are Lewy bodies and Lewy neurites: neuronal inclusions immunopositive for the protein α-synuclein. In-depth ultrastructural analysis of Lewy pathology is crucial to understanding pathogenesis of this disease. Using correlative light and electron microscopy and tomography on postmortem human brain tissue from Parkinson's disease brain donors, we identified α-synuclein immunopositive Lewy pathology and show a crowded environment of membranes therein, including vesicular structures and dysmorphic organelles. Filaments interspersed between the membranes and organelles were identifiable in many but not all α-synuclein inclusions. Crowding of organellar components was confirmed by stimulated emission depletion (STED)-based super-resolution microscopy, and high lipid content within α-synuclein immunopositive inclusions was corroborated by confocal imaging, Fourier-transform coherent anti-Stokes Raman scattering infrared imaging and lipidomics. Applying such correlative high-resolution imaging and biophysical approaches, we discovered an aggregated protein-lipid compartmentalization not previously described in the Parkinsons' disease brain.

Identifiants

pubmed: 31235907
doi: 10.1038/s41593-019-0423-2
pii: 10.1038/s41593-019-0423-2
doi:

Substances chimiques

Membrane Lipids 0
alpha-Synuclein 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1099-1109

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM081653
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Auteurs

Sarah H Shahmoradian (SH)

Center for Cellular Imaging and NanoAnalytics, Biozentrum, University of Basel, Basel, Switzerland.
Department of Biology and Chemistry, Paul Scherrer Institute, Villigen, Switzerland.

Amanda J Lewis (AJ)

Center for Cellular Imaging and NanoAnalytics, Biozentrum, University of Basel, Basel, Switzerland.

Christel Genoud (C)

Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.

Jürgen Hench (J)

Division of Neuropathology, Institute of Pathology, University Hospital Basel, Basel, Switzerland.

Tim E Moors (TE)

Amsterdam Neuroscience, VU University Medical Center, Department of Anatomy and Neurosciences, Section Clinical Neuroanatomy, Amsterdam, The Netherlands.

Paula P Navarro (PP)

Center for Cellular Imaging and NanoAnalytics, Biozentrum, University of Basel, Basel, Switzerland.

Daniel Castaño-Díez (D)

Center for Cellular Imaging and NanoAnalytics, Biozentrum, University of Basel, Basel, Switzerland.

Gabriel Schweighauser (G)

Division of Neuropathology, Institute of Pathology, University Hospital Basel, Basel, Switzerland.

Alexandra Graff-Meyer (A)

Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.

Kenneth N Goldie (KN)

Center for Cellular Imaging and NanoAnalytics, Biozentrum, University of Basel, Basel, Switzerland.

Rosmarie Sütterlin (R)

Center for Cellular Imaging and NanoAnalytics, Biozentrum, University of Basel, Basel, Switzerland.

Evelien Huisman (E)

Amsterdam Neuroscience, VU University Medical Center, Department of Anatomy and Neurosciences, Section Clinical Neuroanatomy, Amsterdam, The Netherlands.

Angela Ingrassia (A)

Amsterdam Neuroscience, VU University Medical Center, Department of Anatomy and Neurosciences, Section Clinical Neuroanatomy, Amsterdam, The Netherlands.

Yvonne de Gier (Y)

Amsterdam Neuroscience, VU University Medical Center, Department of Anatomy and Neurosciences, Section Clinical Neuroanatomy, Amsterdam, The Netherlands.

Annemieke J M Rozemuller (AJM)

Amsterdam Neuroscience, VU University Medical Center, Department of Pathology, Amsterdam, The Netherlands.

Jing Wang (J)

Center for Cellular Imaging and NanoAnalytics, Biozentrum, University of Basel, Basel, Switzerland.

Anne De Paepe (A)

Roche Pharma Research and Early Development, Lead Discovery, Roche Innovation Center Basel, Basel, Switzerland.

Johannes Erny (J)

Roche Pharma Research and Early Development, Preclinical CMC, Roche Innovation Center Basel, Basel, Switzerland.

Andreas Staempfli (A)

Roche Pharma Research and Early Development, Preclinical CMC, Roche Innovation Center Basel, Basel, Switzerland.

Joerg Hoernschemeyer (J)

Roche Pharma Research and Early Development, Preclinical CMC, Roche Innovation Center Basel, Basel, Switzerland.

Frederik Großerüschkamp (F)

Department of Biophysics, Ruhr University, Bochum, Germany.

Daniel Niedieker (D)

Department of Biophysics, Ruhr University, Bochum, Germany.

Samir F El-Mashtoly (SF)

Department of Biophysics, Ruhr University, Bochum, Germany.

Marialuisa Quadri (M)

Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands.

Wilfred F J Van IJcken (WFJ)

Center for Biomics, Erasmus Medical Center, Rotterdam, The Netherlands.

Vincenzo Bonifati (V)

Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands.

Klaus Gerwert (K)

Department of Biophysics, Ruhr University, Bochum, Germany.

Bernd Bohrmann (B)

Roche Pharma Research and Early Development, Neuroscience, Ophthalmology, and Rare Diseases Discovery and Translational Area/Neuroscience Discovery, Roche Innovation Center Basel, Basel, Switzerland.

Stephan Frank (S)

Division of Neuropathology, Institute of Pathology, University Hospital Basel, Basel, Switzerland.

Markus Britschgi (M)

Roche Pharma Research and Early Development, Neuroscience, Ophthalmology, and Rare Diseases Discovery and Translational Area/Neuroscience Discovery, Roche Innovation Center Basel, Basel, Switzerland.

Henning Stahlberg (H)

Center for Cellular Imaging and NanoAnalytics, Biozentrum, University of Basel, Basel, Switzerland. henning.stahlberg@unibas.ch.

Wilma D J Van de Berg (WDJ)

Amsterdam Neuroscience, VU University Medical Center, Department of Anatomy and Neurosciences, Section Clinical Neuroanatomy, Amsterdam, The Netherlands. wdj.vandeberg@vumc.nl.

Matthias E Lauer (ME)

Roche Pharma Research and Early Development, Lead Discovery, Roche Innovation Center Basel, Basel, Switzerland. matthias.lauer@roche.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH